⌘K

Login Start Free

Home/Filings/4/0001190725-17-000148

4//SEC Filing

Mirati Therapeutics, Inc. 4

Accession 0001190725-17-000148

CIK 0001576263operating

View on SEC.gov Company Profile

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 8:26 PM ET

Size

8.1 KB

Accession

0001190725-17-000148

Insider Transaction Report

Form 4

Period: 2017-06-22

Mirati Therapeutics, Inc.MRTX

10% Owner

Transactions

Award
Non-Qualified Stock Option (right to buy)
2017-06-22+25,000→ 25,000 total
Exercise: $4.05Exp: 2027-06-21→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant.

Documents

2 files

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001576263

Filing Metadata

Form type: 4
Filed: Jun 25, 8:00 PM ET
Accepted: Jun 26, 8:26 PM ET
Size: 8.1 KB

View on SEC.gov